Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Tereza Lerchova"'
Autor:
Kristyna Zarubova, Ondrej Fabian, Ondrej Hradsky, Tereza Lerchova, Filip Mikus, Vojtech Dotlacil, Lucie Pos, Richard Skaba, Jiri Bronsky
Publikováno v:
Biomedical Papers, Vol 166, Iss 3, Pp 297-303 (2022)
Aim. Detection of possible predictive factors of endoscopic recurrence after ileocecal resection in Crohn's disease could be very beneficial for the individual adjustment of postoperative therapy. The aim of this study was to verify, whether immunohi
Externí odkaz:
https://doaj.org/article/59e72b967e424b97aae196ec62e7bf8a
Autor:
Tereza Lerchova, Ondrej Hradsky, Michal Kulich, Gabor Veres, Jorge Amil Dias, Małgorzata Sładek, Sanja Kolacek, Stephanie Van Biervliet, Jan Melek, Daniela E. Serban, Katrine Winther, Tim de Meij, Jan Schwarz, Kaija-Leena Kolho, Johanna C. Escher, Jiri Bronsky
Publikováno v:
Lerchova, T, Hradsky, O, Kulich, M, Veres, G, Dias, J A, Sładek, M, Kolacek, S, van Biervliet, S, Melek, J, Serban, D E, Winther, K, de Meij, T, Schwarz, J, Kolho, K-L, Escher, J C & Bronsky, J 2022, ' Prediction of thiopurine failure in pediatric Crohn’s disease : pediatric IBD Porto group of ESPGHAN ', Pediatric Research . https://doi.org/10.1038/s41390-022-02270-x
Pediatric Research, 93(6), 1659-1666. Lippincott Williams & Wilkins
Pediatric Research. Lippincott Williams and Wilkins
Pediatric Research, 93(6), 1659-1666. Lippincott Williams & Wilkins
Pediatric Research. Lippincott Williams and Wilkins
Background Maintaining of remission early in the disease course of Crohn's disease (CD) is essential and has major impact on the future prognosis. This study aimed to identify baseline predictors to develop model allowing stratification of patients w
Autor:
Filip Mikus, Lucie Pos, Kristyna Zarubova, Vojtech Dotlacil, Richard Skaba, Ondrej Hradsky, Tereza Lerchova, Ondrej Fabian, Jiri Bronsky
Publikováno v:
Biomedical Papers. 166:297-303
AIM Detection of possible predictive factors of endoscopic recurrence after ileocecal resection in Crohn's disease could be very beneficial for the individual adjustment of postoperative therapy. The aim of this study was to verify, whether immunohis
Autor:
Jiri Bronsky, Ivana Copova, Marianna Durilova, Denis Kazeka, Michal Kubat, Tereza Lerchova, Eva Vlckova, Katarina Mitrova, Michal Rataj, Adam Klocperk, Anna Sediva, Ondrej Hradsky
Publikováno v:
Journal of Pediatric Gastroenterology & Nutrition.
Autor:
Ondrej Fabian, Adam Klocperk, Tereza Lerchova, Pavla Jencova, Lucie Stolova, Marie Belhajova, Dagmar Voriskova, Denis Kazeka, Ales Vicha, Ondrej Hradsky, Jiri Bronsky
Publikováno v:
Digestive diseases and sciences.
Inflammatory bowel diseases (IBD) frequently manifest in pediatric age, but may have atypical clinical, histological and laboratory features. Their underlying immune pathophysiology is incompletely understood, rendering quick diagnosis followed by ta
Autor:
Tereza, Lerchova, Ondrej, Hradsky, Michal, Kulich, Gabor, Veres, Jorge Amil, Dias, Małgorzata, Sładek, Sanja, Kolacek, Stephanie, Van Biervliet, Jan, Melek, Daniela E, Serban, Katrine, Winther, Tim, de Meij, Jan, Schwarz, Kaija-Leena, Kolho, Johanna C, Escher, Jiri, Bronsky
Publikováno v:
Pediatric research.
Maintaining of remission early in the disease course of Crohn's disease (CD) is essential and has major impact on the future prognosis. This study aimed to identify baseline predictors to develop model allowing stratification of patients who will not
Autor:
Jiri Bronsky, Ivana Copova, Denis Kazeka, Tereza Lerchova, Katarina Mitrova, Kristyna Pospisilova, Miroslava Sulovcova, Kristyna Zarubova, Ondrej Hradsky
Publikováno v:
Clinical and translational gastroenterology. 13(5)
Two antitumor necrosis factor therapies (infliximab [IFX] and adalimumab [ADA]) have been approved for the treatment of pediatric Crohn's disease (CD) but have not been compared in head-to-head trials. The aim of this study was to compare the efficac
Autor:
Kristyna Pospisilova, Tereza Lerchova, Ivana Copova, Denis Kazeka, Jiri Bronsky, Kristyna Zarubova, Ondrej Hradsky, Katarina Mitrova, Miroslava Sulovcova
Publikováno v:
European journal of pediatrics. 180(9)
Studies showing a substantial frequency of dermatologic complications in paediatric Crohn's disease (CD) patients on anti-tumour necrosis factor (TNF) therapy preferentially include patients treated with infliximab. We aimed to identify risk factors
Autor:
Tereza Lerchova, Jiri Nevoral, Ondrej Hradsky, Jiri Bronsky, Kristyna Potuznikova, Kristyna Zarubova, Lucie Gonsorcikova, Ivana Copova
Publikováno v:
European Journal of Pediatrics. 177:1685-1693
Exclusive enteral nutrition (EEN) has been recommended as the first-line therapy in children with active Crohn disease (CD). The primary aim of our study was to determine whether it is possible to use the difference between basal fecal calprotectin (
Autor:
Lubor Urbánek, Ondrej Hradsky, Jiri Bronsky, Eva Karásková, Kristyna Potuznikova, Maria Velganova-Veghova, Jitka Široká, Tereza Lerchova, Michaela Spenerova, Vladimír Mihál
Publikováno v:
Journal of pediatric gastroenterology and nutrition. 69(4)
Therapeutic drug monitoring of thiopurine erythrocyte levels is not available in all centers and it usually requires quite a long time to obtain the results. The aims of this study were to build a model predicting low levels of 6-thioguanine and 6-me